Should I buy or sell Nano-X Imaging stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nano-X Imaging in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NNOX shares. View NNOX analyst ratings or view top-rated stocks .

What is Nano-X Imaging's stock price target for 2024?

2 equities research analysts have issued 1-year price objectives for Nano-X Imaging's stock. Their NNOX share price targets range from $14.50 to $18.00. On average, they anticipate the company's stock price to reach $16.25 in the next year. This suggests a possible upside of 77.6% from the stock's current price. View analysts price targets for NNOX or view top-rated stocks among Wall Street analysts .

How have NNOX shares performed in 2024?

Nano-X Imaging's stock was trading at $6.37 at the beginning of the year. Since then, NNOX shares have increased by 43.6% and is now trading at $9.15. View the best growth stocks for 2024 here .

When is Nano-X Imaging's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024. View our NNOX earnings forecast .

How were Nano-X Imaging's earnings last quarter?

Nano-X Imaging Ltd. (NASDAQ:NNOX) posted its quarterly earnings results on Tuesday, November, 28th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.07. The firm earned $2.48 million during the quarter. Nano-X Imaging had a negative net margin of 613.59% and a negative trailing twelve-month return on equity of 30.27%. During the same period in the prior year, the firm earned ($0.37) earnings per share.

What ETFs hold Nano-X Imaging's stock?

ETFs with the largest weight of Nano-X Imaging (NASDAQ:NNOX) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL) . Amplify BlueStar Israel Technology ETF (ITEQ) .

What other stocks do shareholders of Nano-X Imaging own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nano-X Imaging investors own include NVIDIA (NVDA) , Advanced Micro Devices (AMD) , CrowdStrike (CRWD) , DocuSign (DOCU) , QUALCOMM (QCOM) , Tesla (TSLA) , Zoom Video Communications (ZM) , PayPal (PYPL) , Teladoc Health (TDOC) and Alibaba Group (BABA) .

When did Nano-X Imaging IPO?

Nano-X Imaging (NNOX) raised $100 million in an IPO on Friday, August 21st 2020. The company issued 5,900,000 shares at a price of $16.00-$18.00 per share. Cantor, Oppenheimer, Berenberg and CIBC Capital Markets acted as the underwriters for the IPO and National Securities Corp. was co-manager.

How do I buy shares of Nano-X Imaging?

Shares of NNOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NNOX

Nano-X Imaging (NNOX) Stock Price, News & Analysis

→ Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad)

Free NNOX Stock Alerts

$9.17

+0.05 (+0.55%)

(As of 01:15 PM ET)

Compare

Today's Range: $8.91
▼
$9.28
50-Day Range: $5.65
▼
$12.95
52-Week Range: $4.89
▼
$22.69

Volume: 603,528 shs
Average Volume: 3.55 million shs
Market Capitalization: $505.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.25

Get Nano-X Imaging alerts:

Nano-X Imaging MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 77.6% Upside
$16.25 Price Target
Short Interest: Bearish
16.08% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.63
Based on 4 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.91) to ($0.65) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.23 out of 5 stars

Business Services Sector

264th out of 317 stocks

X-Ray Apparatus & Tubes Industry

2nd out of 4 stocks

3.5

Analyst's Opinion

Consensus Rating
Nano-X Imaging has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Nano-X Imaging has only been the subject of 1 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
16.08% of the outstanding shares of Nano-X Imaging have been sold short.
Short Interest Ratio / Days to Cover
Nano-X Imaging has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Nano-X Imaging has recently increased by 0.23%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Nano-X Imaging does not currently pay a dividend.
Dividend Growth
Nano-X Imaging does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for NNOX.

2.0

News and Social Media Coverage

News Sentiment
Nano-X Imaging has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Nano-X Imaging this week, compared to 2 articles on an average week.
Search Interest
Only 54 people have searched for NNOX on MarketBeat in the last 30 days. This is a decrease of -49% compared to the previous 30 days.
MarketBeat Follows
Only 37 people have added Nano-X Imaging to their MarketBeat watchlist in the last 30 days. This is a decrease of -5% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Nano-X Imaging insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 21.49% of the stock of Nano-X Imaging is held by institutions.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Nano-X Imaging are expected to grow in the coming year, from ($0.91) to ($0.65) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Nano-X Imaging is -8.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Nano-X Imaging is -8.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Nano-X Imaging has a P/B Ratio of 2.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Priority Gold

Biden to Launch “FedNOW” [Move Your Money Now]

Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...

Get your free information kit NOW, before it's too late.

About Nano-X Imaging Stock (NASDAQ:NNOX)

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was incorporated in 2018 and is based in Neve Ilan, Israel.

NNOX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NNOX Stock News Headlines

April 16, 2024 | finance.yahoo.com

Nano-X Imaging Ltd. (NASDAQ:NNOX): Are Analysts Optimistic?

April 14, 2024 | americanbankingnews.com

Nano-X Imaging (NASDAQ:NNOX) Shares Down 4.1%

April 16, 2024 | Wall Street Star (Ad)

This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

April 9, 2024 | globenewswire.com

Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

April 9, 2024 | investing.com

Nano X (NNOX) Earnings Dates & Reports

April 2, 2024 | markets.businessinsider.com

Cantor Fitzgerald Reaffirms Their Buy Rating on Nano-X Imaging (NNOX)

April 2, 2024 | finance.yahoo.com

Nano-X Imaging Ltd. (NASDAQ:NNOX) Q4 2023 Earnings Call Transcript

April 1, 2024 | fool.com

Nano-X Imaging (NNOX) Q4 2023 Earnings Call Transcript

April 16, 2024 | Wall Street Star (Ad)

This Apple-like Innovator is Revolutionizing Healthcare

April 1, 2024 | seekingalpha.com

Nano-X Imaging: System Deployments Finally Begin

April 1, 2024 | globenewswire.com

Nanox Announces Fourth Quarter of 2023 Financial Results and Provides Business Update

March 26, 2024 | fool.com

Is Nano-X Imaging Stock a Buy in the New Bull Market?

March 20, 2024 | wsj.com

Nano-X Imaging Ltd.

March 19, 2024 | finance.yahoo.com

NNOX Nov 2024 12.500 call

March 18, 2024 | globenewswire.com

Nanox to Report Fourth Quarter and Fiscal Year 2023 Financial Results on April 1, 2024

March 13, 2024 | benzinga.com

Latest News for Nano X Imaging Stock (NASDAQ:NNOX)

March 12, 2024 | globenewswire.com

Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold

March 6, 2024 | fool.com

Here's Why Nano-X Stock More Than Doubled Last Month

February 29, 2024 | fool.com

Nano-X Imaging Could Be Teaming Up With Nvidia, and Its Stock Is Flying. Can It Continue?

February 29, 2024 | globenewswire.com

Nanox and Beilinson Hospital Announce Collaboration to Study Diagnostic Capabilities of Nanox.ARC for Detection of Lung and Chest Diseases

February 22, 2024 | msn.com

Nano-X Imaging Stock (NASDAQ:NNOX): Settling Down from Nvidia-linked Volatility Spike

February 22, 2024 | fool.com

These 2 Healthcare Stocks Are in Nvidia's Portfolio. Should They Be in Yours?

February 21, 2024 | investorplace.com

Nvidia Is Investing in These 3 Stocks. Should You?

February 21, 2024 | fool.com

Nvidia Just Invested in These 5 Artificial Intelligence (AI) Stocks. Here's the Best of the Bunch.

February 20, 2024 | msn.com

Nano X Imaging, Annexon among healthcare movers

February 19, 2024 | fool.com

Investors Are Piling Into Nvidia Stock. But Nvidia Is Investing in 5 Other AI Stocks.

February 16, 2024 | msn.com

What's Going On With Nano-X Imaging (NNOX) Stock?

See More Headlines

Receive NNOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nano-X Imaging and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/28/2023
Today: 4/16/2024
Next Earnings (Estimated): 5/27/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: NASDAQ:NNOX
CUSIP: N/A
CIK: 1795251
Web: www.nanox.vision
Phone: 972-02-536-0360
Fax: 972-02-544-5214
Employees: 180
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $16.25
High Stock Price Target: $18.00
Low Stock Price Target: $14.50
Potential Upside/Downside: +78.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.07)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-60,780,000.00
Net Margins: -613.59%
Pretax Margin: -1,085.65%
Return on Equity: -30.27%
Return on Assets: -26.23%

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 4.87
Quick Ratio: 4.87

Sales & Book Value

Annual Sales: $9.90 million
Price / Sales: 50.80
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $4.16 per share
Price / Book: 2.19

Miscellaneous

Outstanding Shares: 55,150,000
Free Float: N/A
Market Cap: $502.97 million
Optionable: Optionable
Beta: 2.15

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Mr. Erez I. Meltzer (Age 67)
CEO & Director
Comp: $1.86M
Mr. James M. Dara (Age 54)
GM of Source & Services Division and Head of Nanox USA
Comp: $376.84k
Mr. Ofir Koren (Age 54)
General Manager of Nanox.ARC Division
Comp: $335.81k
Mr. Ran Daniel (Age 56)
Chief Financial Officer
Ms. Marina Gofman Feler (Age 35)
Chief Legal Officer
Ms. Tamar Aharon Cohen (Age 47)
Executive VP & Chief Marketing Officer
Dr. Orit Wimpfheimer (Age 53)
Chief Medical Officer & VP of Product Nanox AI
Ms. Gali Yahav Attias (Age 45)
VP of Corporate Resources & Chief of Staff
Dr. Guy Yoskovitz Ph.D. (Age 45)
Chief Clinical Officer
Michael Attias
VP & Head of Robodiology

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

NNOX Stock Analysis - Frequently Asked Questions

Should I buy or sell Nano-X Imaging stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nano-X Imaging in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" NNOX shares.
View NNOX analyst ratings or view top-rated stocks.
What is Nano-X Imaging's stock price target for 2024?: 2 equities research analysts have issued 1-year price objectives for Nano-X Imaging's stock. Their NNOX share price targets range from $14.50 to $18.00. On average, they anticipate the company's stock price to reach $16.25 in the next year. This suggests a possible upside of 77.6% from the stock's current price.
View analysts price targets for NNOX or view top-rated stocks among Wall Street analysts.
How have NNOX shares performed in 2024?: Nano-X Imaging's stock was trading at $6.37 at the beginning of the year. Since then, NNOX shares have increased by 43.6% and is now trading at $9.15.
View the best growth stocks for 2024 here.
When is Nano-X Imaging's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our NNOX earnings forecast.
How were Nano-X Imaging's earnings last quarter?: Nano-X Imaging Ltd. (NASDAQ:NNOX) posted its quarterly earnings results on Tuesday, November, 28th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.30) by $0.07. The firm earned $2.48 million during the quarter. Nano-X Imaging had a negative net margin of 613.59% and a negative trailing twelve-month return on equity of 30.27%. During the same period in the prior year, the firm earned ($0.37) earnings per share.

What ETFs hold Nano-X Imaging's stock?: ETFs with the largest weight of Nano-X Imaging (NASDAQ:NNOX) stock in their portfolio include ARK Israel Innovative Technology ETF (IZRL).Amplify BlueStar Israel Technology ETF (ITEQ).
What other stocks do shareholders of Nano-X Imaging own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Nano-X Imaging investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), CrowdStrike (CRWD), DocuSign (DOCU), QUALCOMM (QCOM), Tesla (TSLA), Zoom Video Communications (ZM), PayPal (PYPL), Teladoc Health (TDOC) and Alibaba Group (BABA).
When did Nano-X Imaging IPO?: Nano-X Imaging (NNOX) raised $100 million in an IPO on Friday, August 21st 2020. The company issued 5,900,000 shares at a price of $16.00-$18.00 per share. Cantor, Oppenheimer, Berenberg and CIBC Capital Markets acted as the underwriters for the IPO and National Securities Corp. was co-manager.
How do I buy shares of Nano-X Imaging?: Shares of NNOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NNOX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial